Curcumin impact on diabetes

Curcumin improves inflammatory markers in patients with diabetes

Study demonstrates curcumin improves dyslipidemia and inflammatory markers in patients with diabetes

Curcumin impact on diabetes

Curcumin is the natural compound known for its wide range of protective properties. It is derived from turmeric root, the bright yellow-orange spice popular as the main ingredient in Indian curry powders. Turmeric’s high concentration of curcumin underlies the centuries-old use of this root in Ayurveda, traditional Indian medicine.

Effects of curcumin supplementation on patients with diabetes

According to a new study, researchers demonstrated the effect of curcumin supplementation on inflammatory markers and lipid profiles of patients with diabetes.

This double-blind randomized clinical trial included forty-four patients with type 2 diabetes. Each patient was randomly assigned to take 1500 mg of curcumin or a placebo per day for a ten-week period. Laboratory assessments, including a lipid panel, high-sensitivity C-reactive protein (hs-crp), and adiponectin, as well as anthropometric measurements,  were taken at baseline and at the study’s completion.

Significant reduction in serum triglycerides in patients who consumed curcumin

Results showed a significant reduction in serum triglycerides in the patients who consumed the curcumin for the ten-week period. In addition, hs-crp levels decreased and there was an increase in adiponectin, a fat-burning hormone, compared to the placebo. These results indicate the benefits of curcumin supplementation in patients with diabetes.

Curcumin promotes changes in expression of genes involved in cholesterol synthesis

Earlier studies have shown that curcumin promotes changes in the expression of genes involved in cholesterol synthesis, such as the LDL receptor mRNA, HMG CoA reductase, SREBP, cholesterol 7 alpha hydrolyze, PPAR, and LXR1.1,2 One human study demonstrated that 500 mg of curcumin per day increased HDL cholesterol by 29% and reduced total cholesterol by 12%.2

Previously, I shared a study3 from Complementary Therapies in Medicine on curcumin and dyslipidemia in diabetic patients. In this study, researchers demonstrated that curcuminoid supplementation of 1000 mg daily for 12 weeks can reduce lipoprotein(a) and increase HDL-C.

Tools to assess cardiovascular health

Health care providers have many tools today to assess cardiovascular health and support the body’s physiology. These include advanced lipid profiles, inflammatory markers (ferritin, hs-CRP, fibrinogen), nutrient markers (magnesium, potassium, selenium, copper, folate, B12, B6, and zinc), fat-soluble vitamins (CoQ10, vitamin D, vitamin K, Vitamin A, and tocotrienols), oxidative stress factors (homocysteine, insulin, and lipid peroxidases), heavy metals, and fatty acid profiles. A successful treatment approach should include a comprehensive investigation of these factors in order to perform a thorough assessment for these patients.

 


Research and References

By Designs for Health USA researcher and writer, Michael Jurgelewicz, DC, DACBN, DCBCN, CNS

Source: Adibian M, Hodaei H, et al. The effects of curcumin supplementation on high-sensitivity C-reactive protein, serum adiponectin, and lipid profile in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial. Phytother Res. 2019 March 12.

Additional Resources

  1. Houston MC, Fazio S, Chilton FH, Wise DE, Jones KB, Barringer TA, and Bramlet DA. Non-pharmacologic treatment of dyslipidemia. Prog Cardiovasc Dis 2009; 52: 61–94.
  2. Soni KB and Kuttan R. Effect of oral curcumin administration on serum peroxides and cholesterol levels in human volunteers. Indian J Physiol Pharmacol 1992; 36(4): 273–75.

Ferguson J, Stojanovski E et al. Curcumin potentiates cholesterol-lowering effects of phytosterols in hypercholesterolemic individuals. A randomised controlled trial. Metabolism 2017 Dec 29.